March 16, 2026 – Last month TAG attended the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) to learn more about updates on TB prevention and treatment for people living with HIV, pregnant persons, and children and results from research on short-course preventive therapy, treatment dosing strategies, and emerging long-acting technologies. Read a summary of key studies and TAG’s analysis here.
Please note that the “Posted on” date reflects the date that the news archives were transferred to NTCA’s redesigned website, not the date of the original news item.
